Lipella Pharmaceuticals Inc: Got Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard From Nasdaq
Lipella Pharmaceuticals Inc: 收到納斯達克的退市通知或未能滿足持續上市規則或標準
Lipella Pharmaceuticals Inc: Got Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard From Nasdaq
Lipella Pharmaceuticals Inc: 收到納斯達克的退市通知或未能滿足持續上市規則或標準
譯文內容由第三人軟體翻譯。